PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25261710-3	2014	In the present study, dipeptide prodrug approach was employed to circumvent efflux pumps (P-gp and MRP2) and CYP3A4 mediated metabolism of LPV.	Dipeptides	22-31	ATP binding cassette subfamily C member 2	Canis lupus familiaris	99-103	
18620036-0	2008	Interaction of dipeptide prodrugs of saquinavir with multidrug resistance protein-2 (MRP-2): evasion of MRP-2 mediated efflux.	Dipeptides	15-24	ATP binding cassette subfamily C member 2	Canis lupus familiaris	53-83	
18620036-0	2008	Interaction of dipeptide prodrugs of saquinavir with multidrug resistance protein-2 (MRP-2): evasion of MRP-2 mediated efflux.	Dipeptides	15-24	ATP binding cassette subfamily C member 2	Canis lupus familiaris	85-90	
18620036-0	2008	Interaction of dipeptide prodrugs of saquinavir with multidrug resistance protein-2 (MRP-2): evasion of MRP-2 mediated efflux.	Dipeptides	15-24	ATP binding cassette subfamily C member 2	Canis lupus familiaris	104-109	
18620036-3	2008	The objective of this study was to investigate whether derivatization of SQV to dipeptide prodrugs, valine-valine-saquinavir (Val-Val-SQV) and glycine-valine-saquinavir (Gly-Val-SQV), targeting peptide transporter can circumvent MRP-2 mediated efflux.	Dipeptides	80-89	ATP binding cassette subfamily C member 2	Canis lupus familiaris	229-234